Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.
NUTX
STRONG BUYREMOVENutex Health Inc. · Healthcare · United States · $1.1B · Avg Vol: $26M/d
While the healthcare sector can be defensive, Nutex lacks the durable competitive advantage and high-ROIC profile required. The business model of freestanding emergency rooms faces constant regulatory scrutiny and reimbursement uncertainty, failing the Terry Smith quality test.
COMPANY DESCRIPTION
Nutex Health Inc. operates a national network of micro-hospitals, primary care clinics, and independent physician associations, providing integrated healthcare services. Its focus on smaller, community-based micro-hospitals and value-based care models differentiates it in a fragmented healthcare market. The company is a niche player in micro-hospital development, pursuing a capital-efficient expansion strategy.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 219.3M | 247.6M | 479.9M | 875.3M | 58.6% | 880.0M | 880.3M | 969.2M | 5.2% |
| EPS | -100.50 | -10.50 | 10.25 | 11.13 | 8.6% | 13.94 | 21.52 | 23.03 | 43.8% |
| Shares | 4.3M | 4.5M | 5.5M | 7.1M | +63.5% | 6.9M | — | — | — |
| Debt | 267.2M | 275.8M | 340.3M | 351.4M | 9.6% | 349.1M | — | — | — |
| Equity | 95.9M | 61.5M | 132.4M | 329.4M | 50.9% | — | — | — | — |
| Op CF | 50.6M | 1.3M | 23.2M | 248.1M | 69.9% | 272.7M | — | — | — |
| Inv CF | -4.3M | -11.2M | -5.6M | -5.2M | — | — | — | — | — |
| Fin CF | -48.1M | -2.3M | 1.1M | -97.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NUTX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NUTX | Nutex Health Inc.(you) | $1.1B | 100 | STRONG BUY |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 95 | STRONG BUY |
| ARDT | Ardent Health, Inc. | $1.4B | 91 | STRONG BUY |
| HCSG | Healthcare Services Group, Inc. | $1.7B | 94 | STRONG BUY |
| MD | Pediatrix Medical Group, Inc. | $2.0B | 97 | STRONG BUY |
| AVAH | Aveanna Healthcare Holdings Inc. | $1.9B | 94 | STRONG BUY |
| ADUS | Addus HomeCare Corporation | $1.8B | 91 | STRONG BUY |
| GRDN | Guardian Pharmacy Services, Inc. | $2.7B | 91 | STRONG BUY |
| ASTH | Astrana Health, Inc. | $2.2B | 87 | STRONG BUY |
| SEM | Select Medical Holdings Corporation | $2.0B | 85 | STRONG BUY |
Peer medians: ROE -21.3% · P/E 27.3x · Gross margin 44.3%